Description

As I sat writing this ‘personal reflections’ manuscript in the spring of 2015, I was seeing press reports related to the use of tobacco to make an Ebola therapeutic called

As I sat writing this ‘personal reflections’ manuscript in the spring of 2015, I was seeing press reports related to the use of tobacco to make an Ebola therapeutic called ZMapp. For several months newspaper articles, radio shows and hour-long TV documentaries have given the public unprecedented exposure to the fact that ‘plant-made pharmaceuticals’ (PMP) can be life-saving drugs. I have been asked by many nonspecialists – why tobacco? How can this work?

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2015-09-08
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1111/pbi.12460
    • Identifier Type
      International standard serial number
      Identifier Value
      1467-7644
    • Identifier Type
      International standard serial number
      Identifier Value
      1467-7652
    Note

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Arntzen, C. (2015). Plant-made pharmaceuticals: from ‘Edible Vaccines’ to Ebola therapeutics. Plant Biotechnology Journal, 13(8), 1013-1016. doi:10.1111/pbi.12460

    Machine-readable links